## Abstract An erratum for this article appears in the January, 2004 issue of __Movement__ Disorders (Mov Disord 2004;19:119). Parkinson's disease (PD) is a common neurodegenerative disorder characterized by the progressive loss of the dopaminergic neurons in the substantia nigra pars compacta (SN
Role of glial cells in neurotoxin-induced animal models of Parkinson’s disease
✍ Scribed by Hironori Yokoyama; Hiroto Uchida; Hayato Kuroiwa; Jiro Kasahara; Tsutomu Araki
- Publisher
- Springer Milan
- Year
- 2010
- Tongue
- English
- Weight
- 273 KB
- Volume
- 32
- Category
- Article
- ISSN
- 1590-1874
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract The original article to which this Clarification refers was published in the February 2003 issue of __Movement__ Disorders (Teismann P, Tieu K, Cohen O, Choi DK, Wu dC, Marks D, Vila M, Jackson‐Lewis V, Przedborski S. Pathogenic role of glial cells in Parkinson's disease. Mov Disord 200
## Abstract Animal models are important tools in experimental medical science to better understand pathogenesis of human diseases. Once developed, these models can be exploited to test therapeutic approaches for treating functional disturbances observed in the disease of interest. On the basis of e
## Abstract ## Background: Parkinson's disease is a progressive neurodegenerative disorder mainly characterized by the loss of dopaminergic neurons from the substantia nigra pars compacta and the presence, in the affected brain regions, of protein inclusions named Lewy Bodies. Despite the fact tha
Sperlágh et al.: The double-faced role of P2X 7 receptors in toxin-induced animal models of Parkinson's disease. BMC Pharmacology 2011 11(Suppl 2):A56.